Inotiv Financials

NOTV Stock  USD 3.10  0.01  0.32%   
Based on the key indicators related to Inotiv's liquidity, profitability, solvency, and operating efficiency, Inotiv Inc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April. At this time, Inotiv's Cash And Short Term Investments are fairly stable compared to the past year. Net Receivables is likely to climb to about 88.8 M in 2025, despite the fact that Net Debt is likely to grow to (6.7 M). Key indicators impacting Inotiv's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.07680.0808
Notably Down
Very volatile
Current Ratio1.31.58
Significantly Down
Slightly volatile
The essential information of the day-to-day investment outlook for Inotiv includes many different criteria found on its balance sheet. An individual investor should monitor Inotiv's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Inotiv.

Net Income

(92.72 Million)

  

Inotiv Inc Earnings Geography

Please note, the imprecision that can be found in Inotiv's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Inotiv Inc. Check Inotiv's Beneish M Score to see the likelihood of Inotiv's management manipulating its earnings.

Inotiv Stock Summary

Inotiv competes with Fonar, Burning Rock, Sera Prognostics, Exagen, and Sotera Health. Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries and sells analytical instruments to the pharmaceutical development and contract research industries. Inotiv, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana. Inotiv operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 541 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS45783Q1004
CUSIP45783Q100 09058M103
LocationIndiana; U.S.A
Business Address2701 Kent Avenue,
SectorLife Sciences Tools & Services
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.inotiv.com
Phone765 463 4527
CurrencyUSD - US Dollar

Inotiv Key Financial Ratios

Inotiv Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets321.9M962.9M856.5M781.4M898.6M943.5M
Other Current Liab8.9M103.2M57.9M65.8M75.7M79.4M
Net Debt35.3M368.0M382.1M(6.1M)(7.0M)(6.7M)
Retained Earnings(11.0M)(348.3M)(453.3M)(562.2M)(505.9M)(480.6M)
Accounts Payable6.2M28.7M32.6M33.5M38.6M40.5M
Cash138.9M18.5M35.5M21.4M24.6M25.9M
Net Receivables28.4M100.1M90.4M73.6M84.6M88.8M
Inventory602K71.4M56.1M18.2M20.9M21.9M
Other Current Assets21.1M76.8M31.8M50.2M57.8M60.7M
Total Liab216.7M603.1M588.0M610.9M702.5M737.6M
Total Current Assets189.0M233.0M213.8M163.4M187.9M197.3M
Short Term Debt13.4M31.0M18.2M15.3M17.6M18.5M
Intangible Assets24.2M345.9M308.4M274.4M315.6M331.3M
Common Stock2.7M3.9M6.4M6.4M7.4M7.7M
Good Will4.4M51.9M157.8M94.3M84.9M56.3M
Net Tangible Assets4.2M(1.1M)29.0M(143.3M)(129.0M)(122.6M)
Other Assets231K8.9M281K7.4M8.6M9.0M
Long Term Debt154.2M330.7M369.8M389.8M448.3M470.7M
Net Invested Capital270.7M714.0M646.9M563.8M648.4M680.8M
Short Long Term Debt11.4M23.0M8.0M3.5M4.1M8.0M
Net Working Capital133.9M68.9M81.6M44.4M51.0M41.4M
Capital Stock3.9M6.4M6.4M6.5M7.4M4.9M

Inotiv Key Income Statement Accounts

The reason investors look at the income statement is to determine what Inotiv's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
202020212022202320242025 (projected)
Interest Expense1.7M29.7M43.0M46.9M42.2M24.0M
Total Revenue89.6M547.7M572.4M490.7M564.3M592.6M
Gross Profit30.2M157.2M165.4M111.2M127.8M134.2M
Operating Income1.5M(27.4M)(81.5M)(86.4M)(77.8M)(73.9M)
Ebit7.8M(322.7M)(81.2M)(83.9M)(75.5M)(71.7M)
Ebitda15.4M(273.4M)(26.5M)(26.8M)(24.1M)(22.9M)
Cost Of Revenue59.4M390.4M407.0M379.6M436.5M458.3M
Income Before Tax6.1M(352.4M)(124.2M)(130.8M)(117.7M)(111.8M)
Net Income10.9M(337.3M)(105.1M)(108.4M)(97.6M)(92.7M)
Income Tax Expense(4.8M)(15.2M)(19.3M)(21.9M)(19.7M)(18.7M)
Tax Provision(4.8M)(15.2M)(19.3M)(21.9M)(19.7M)(18.7M)
Net Interest Income(1.7M)(29.7M)(43.0M)(46.9M)(42.2M)(40.1M)

Inotiv Key Cash Accounts

202020212022202320242025 (projected)
Change In Cash155.5M(137.9M)16.5M(14.1M)(12.7M)(12.0M)
Free Cash Flow(1.7M)(41.5M)380K(29.1M)(26.2M)(24.9M)
Depreciation6.3M49.3M54.7M57.1M65.7M69.0M
Other Non Cash Items(12.9M)316.6M79.1M8.9M10.2M16.8M
Capital Expenditures12.5M36.3M27.5M22.3M25.7M26.9M
Net Income10.9M(337.3M)(104.9M)(108.9M)(98.0M)(93.1M)
End Period Cash Flow156.9M19.0M35.5M21.4M24.6M25.9M
Investments(54.1M)(333.7M)(28.8M)(16.8M)(15.1M)(15.9M)
Net Borrowings6.3M9.7M131.9M225.0M258.7M271.7M
Change To Netincome120K47K(2.8M)302.1M347.4M364.7M

Inotiv Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Inotiv's current stock value. Our valuation model uses many indicators to compare Inotiv value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Inotiv competition to find correlations between indicators driving Inotiv's intrinsic value. More Info.
Inotiv Inc is rated below average in return on equity category among its peers. It is regarded third in return on asset category among its peers . At this time, Inotiv's Return On Equity is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Inotiv by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Inotiv Inc Systematic Risk

Inotiv's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Inotiv volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Inotiv Inc correlated with the market. If Beta is less than 0 Inotiv generally moves in the opposite direction as compared to the market. If Inotiv Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Inotiv Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Inotiv is generally in the same direction as the market. If Beta > 1 Inotiv moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Inotiv Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Inotiv's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Inotiv growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(0.0102)

At this time, Inotiv's Price Earnings To Growth Ratio is fairly stable compared to the past year.

Inotiv March 19, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Inotiv help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Inotiv Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Inotiv Inc based on widely used predictive technical indicators. In general, we focus on analyzing Inotiv Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Inotiv's daily price indicators and compare them against related drivers.

Additional Tools for Inotiv Stock Analysis

When running Inotiv's price analysis, check to measure Inotiv's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inotiv is operating at the current time. Most of Inotiv's value examination focuses on studying past and present price action to predict the probability of Inotiv's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inotiv's price. Additionally, you may evaluate how the addition of Inotiv to your portfolios can decrease your overall portfolio volatility.